Clinical Trial Update: Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating tesamorelin for cognitive function in aging HIV-infected persons with mild cognitive impairment has completed. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Tesamorelin (tesamorelin)

Snippet

Sponsor: University of California, San Diego | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2026-03-12